Molecular Diagnostics for Cancer Drug Development

Venue: Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Jun 28, 2011 End Date/Time: Jun 30, 2011
Report as Spam


This is the must-attend forum for cancer and diagnostic professionals trying to navigate the biomarker-driven oncology drug development space. Designed with the community in mind, the summit will address the core challenges you’re facing throughout oncology drug development, from biomarker discovery and assay validation through to companion diagnostic development, amongst other things. We've worked with the experts of the MDx in oncology world - Genentech, Amgen Pfizer, Centocor, Asuragen, Medco and so many others, and this is the result.

Building on the huge success of Molecular Diagnostics for Cancer Drug Development 2010, this industry gathering again brings together the perfect blend of world beating speakers, innovative drug developers and expert solution providers to meet, learn and network. Take home new ideas and MDx-specific contacts (within oncology) that will drive your business and research forward.

Why attend?

• Meet every major stakeholder in the MDx for oncology field from pharma, biotech, academia, top solution providers and everything in between. Understand how they are using innovative new technologies and approaches to accelerate progress in anti-cancer drug development.
• Leave the meeting with a surplus of new ideas, and contacts to take back to your organization.
• MDx for Cancer Drug Development focusses on delivering practical value, pushing existing boundaries in the personalized healthcare sector and helping to grow your business and/or research.

For more information or to register simply:

Call: +1 212 537 5898

Please quote the booking code: CONFLIST when registering to claim an extra 10% discount.